Skip to main content
logo
Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
544.52
+2.83 (0.52%)
At close: Aug 31, 2026, 4:00 PM EDT
545.80
+1.28 (0.24%)
After-hours: Aug 31, 2026, 7:58 PM EDT

Vertex Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Revenue
3,3342,9873,1903,0762,9442,7602,9122,7722,6462,6912,5182,4842,4932,3752,3032,3342,1962,0982,0731,984
Other Revenue
----20.710--------------
Revenue
3,3342,9873,1903,0762,9652,7702,9122,7722,6462,6912,5182,4842,4932,3752,3032,3342,1962,0982,0731,984
Revenue Growth (YoY)
12.45%7.82%9.55%10.98%12.06%2.96%15.66%11.61%6.11%13.30%9.34%6.39%13.52%13.22%11.10%17.65%22.46%21.64%27.32%28.98%
Cost of Revenue
1,4831,3541,4401,3931,3861,3431,4221,2691,3391,1321,1931,1291,0941,010977.4934.4848.9846.9815.2703.5
Gross Profit
1,8511,6331,7501,6841,5791,4281,4901,5031,3071,5591,3251,3551,3991,3651,3251,4001,3471,2511,2571,281
Selling, General & Admin
582.2493.7487445.1424.6396.4377.6371.8372.2342.7369.1263.8262.6241.1267.4246.8215.3215.2255.2198.2
Operating Expenses
582.2493.7487445.1424.6396.4377.6371.8372.2342.7369.1263.8262.6241.1267.4246.8215.3215.2255.2198.2
Operating Income
1,2691,1391,2631,2391,1541,0311,1121,132934.91,2169561,0911,1361,1241,0581,1531,1321,0351,0021,082
Interest Expense
---3.3-3.3---2.8-7.5-9.9-10.4-10.6-10.9-11.2-11.4-11.6-13.7-14.6-14.9-15.1-15.2
Interest & Investment Income
120.6114.8121.9125.7118.7117.9128.2132.2156.5181.2179.5167.9144.7122.68646.210.81.61.21.1
Currency Exchange Gain (Loss)
-13.42.913.5-22.9-3.1-1.2-11.60.1-13.4-2.4-6.8-220.63.623.8-22.1-8.4-8.4-4.5-0.4
Other Non Operating Income (Expenses)
46.2-6.7-14.314.69.9-1.4-6.4-19.83-26.1-2.612.3-8.2-8.7-48.939.314.511.2-0.5-3.9
EBT Excluding Unusual Items
1,4221,2501,3811,3531,2801,1461,2201,2371,0711,3591,1161,2381,2621,2301,1071,2031,1341,025983.31,064
Gain (Loss) on Sale of Investments
-8.53.87.3-1.56.4-153.12.8-12.7-2.7-0.4-6.29.26.4-6--84.2-75.612.146.7
Asset Writedown
------379-----------13---
Other Unusual Items
-0.4-0.2-0.91.9-0.9-2.21.2-0.3-0.50.150.3-1.20.61.9-1.82.649.27.52-1.2
Pretax Income
1,3921,2531,3311,2991,283730.41,1371,224-3,3911,2791,1481,1791,162891.51,0771,1761,024954.8870.91,083
Income Tax Expense
292221.5139.9215.9250.184.1223.5178.7202.4179.5178.8143.9245.8191.7257.9245.9213.9192.7100.8230.9
Earnings From Continuing Operations
1,1001,0311,1911,0831,033646.39131,045-3,5941,100968.81,035915.7699.8818.9930.5810.5762.1770.1851.9
Net Income
1,1001,0311,1911,0831,033646.39131,045-3,5941,100968.81,035915.7699.8818.9930.5810.5762.1770.1851.9
Net Income to Common
1,1001,0311,1911,0831,033646.39131,045-3,5941,100968.81,035915.7699.8818.9930.5810.5762.1770.1851.9
Net Income Growth (YoY)
6.48%59.59%30.46%3.59%--41.22%-5.76%0.98%-57.13%18.30%11.26%12.98%-8.18%6.34%9.23%1109.70%16.69%27.45%27.64%
Shares Outstanding (Basic)
254254254256257257258258258258258258258257257257256255255258
Shares Outstanding (Diluted)
255256256258259260261261258261261261260260260260259258257260
Shares Change (YoY)
-1.43%-1.23%-1.69%-1.30%0.31%-0.61%-0.15%0.15%-0.88%0.31%0.23%0.42%0.66%0.93%1.28%-0.08%-0.88%-1.53%-2.32%-1.66%
EPS (Basic)
4.344.064.694.244.022.523.554.05-13.924.263.764.013.552.723.193.633.172.993.023.30
EPS (Diluted)
4.314.024.654.203.992.493.504.01-13.924.213.713.973.522.693.143.593.132.962.993.28
EPS Growth (YoY)
8.02%61.45%32.88%4.74%--40.86%-5.64%1.01%-56.51%18.08%10.59%12.46%-9.12%5.02%9.45%1109.96%18.88%30.38%29.64%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
1,0131,295348.61,140927.4778.24921,302-3,8231,238176.51,2281,075857.81,045901.31,087892.6933.2874.8
Free Cash Flow Per Share
3.975.051.364.423.583.001.894.99-14.814.740.684.714.133.294.013.474.203.463.633.37
Gross Margin
55.52%54.66%54.87%54.74%53.25%51.53%51.16%54.24%49.41%57.94%52.63%54.55%56.11%57.49%57.55%59.97%61.35%59.62%60.67%64.54%
Operating Margin
38.05%38.13%39.60%40.27%38.93%37.22%38.20%40.82%35.34%45.20%37.97%43.93%45.58%47.34%45.94%49.40%51.54%49.36%48.35%54.55%
Profit Margin
32.99%34.53%37.34%35.20%34.84%23.33%31.35%37.71%-135.83%40.87%38.48%41.69%36.73%29.47%35.56%39.86%36.91%36.33%37.16%42.94%
Free Cash Flow Margin
30.39%43.35%10.93%37.04%31.28%28.09%16.90%46.98%-144.49%46.02%7.01%49.44%43.11%36.12%45.37%38.61%49.47%42.55%45.03%44.09%
EBITDA
1,3251,1951,2881,2931,2061,0801,1341,185988.91,2701,0031,1331,1781,1631,0961,1901,1691,0711,0361,114
EBITDA Margin
39.75%40.00%40.37%42.02%40.67%38.97%38.93%42.74%37.38%47.19%39.85%45.63%47.24%48.97%47.61%50.97%53.24%51.08%49.99%56.15%
D&A For EBITDA
56.555.924.55451.748.421.353.25453.547.242.141.438.838.436.737.335.933.831.7
EBIT
1,2691,1391,2631,2391,1541,0311,1121,132934.91,2169561,0911,1361,1241,0581,1531,1321,0351,0021,082
EBIT Margin
38.05%38.13%39.60%40.27%38.93%37.22%38.20%40.82%35.34%45.20%37.97%43.93%45.58%47.34%45.94%49.40%51.54%49.36%48.35%54.55%
Effective Tax Rate
20.98%17.68%10.51%16.62%19.49%11.51%19.67%14.60%-14.03%15.58%12.20%21.16%21.50%23.95%20.90%20.88%20.18%11.57%21.32%
Revenue as Reported
3,3342,9873,1903,0762,9652,7702,9122,7722,6462,691----8,931---2,0731,984
SEC Filings: 10-K · 10-Q